Tag results:
adipocytes
Immune Regulation News
Resident and Migratory Adipose Immune Cells Control Systemic Metabolism and Thermogenesis
[Cellular & Molecular Immunology] Investigators review the key findings that have shaped our understanding of how immune cells regulate adipose tissue homeostasis to control organismal metabolism.
Hepatic Cell News
Natural Killer Cell-Derived Exosomal miR-1249-3p Attenuates Insulin Resistance and Inflammation in Mouse Models of Type 2 Diabetes
[Signal Transduction and Targeted Therapy] The authors showed that natural killer (NK)-derived exosomes from lean mice attenuated obesity-induced insulin resistance and inflammation in mice of type 2 diabetes, and that lean NK-derived exosomes enhanced insulin sensitivity and relieve inflammation in adipocytes and hepatocytes.
Cell Therapy News
CRISPR-Enhanced Human Adipocyte Browning as Cell Therapy for Metabolic Disease
[Nature Communications] Scientists applied methods to greatly expand human adipocyte progenitors from small samples of human subcutaneous adipose tissue and then disrupt the thermogenic suppressor gene NRIP1 by CRISPR.
Mammary Cell News
Adipocyte-Derived Exosomes May Promote Breast Cancer Progression in Type 2 Diabetes
[Science Signaling] Researchers found that primary human adipocytes shed extracellular vesicles, specifically exosomes, that induced the expression of genes associated with epithelial-to-mesenchymal transition and cancer stem–like cell traits in cocultured breast cancer cell lines.
Endothelial Cell News
Insulin-Stimulated Adipocytes Secrete Lactate to Promote Endothelial Fatty Acid Uptake and Transport
[Journal of Cell Science] Investigators modeled the relationship of adipocytes and endothelial cells in vitro to test the role of insulin in fatty acid transport.
Mesenchymal Cell News
Clinical Application of Mesenchymal Stem Cells in Rheumatic Diseases
[Stem Cell Research & Therapy] In recent years, the application of MSCs in rheumatic diseases has received increasing attention. The authors review the clinical progress in MSC application for the treatment of rheumatic diseases.